Pursuant to Regulation 30, Sub- Para 15 of Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular No. SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 and in continuation to our earlier intimation, dated May 19, 2025, regarding the Analysts/Investors Earning Call scheduled to be held on May 26, 2026 at 04:30 PM (IST), Orchid Pharma has enclosed Investors Presentation, including the financial performance and business information of the Company for the Quarter-IV and Financial Year ended March 31, 2026. The Investor Presentation is also made available on the website of the Company at https://www.orchidpharma.com/
The above information is a part of company’s filings submitted to BSE.
